Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (161-170 of 326) with videos related to

Pageof 33
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|October 14, 2017
Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation studyRamy Younes, Chiara Rosso, Salvatore Petta, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatideMark L Hartman, Rohit Loomba, Eric J Lawitz, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2015
Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort studyClaudia Coppo, Daria Bonfanti, Simona Bo, et al.
Cancers|October 1, 2020
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular CarcinomaGian Paolo Caviglia, Michela Ciruolo, Antonella Olivero, et al.
NPJ Science of Food|March 5, 2026
Gut microbiome modulation by cricket, pea, and whey protein using the SHIME in vitro simulatorIrene Franciosa, Gabriele Castelnuovo, Carolina Cantele, et al.
International Journal of Cardiology|March 2, 2023
Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysisFabrizio D'Ascenzo, Francesco Bruno, Mario Iannaccone, et al.
Journal of Clinical Medicine|July 29, 2020
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with <i>Bifidobacterium Longum</i> ES1 for 8 or 12 Weeks: A Preliminary ReportGian Paolo Caviglia, Alessandra Tucci, Rinaldo Pellicano, et al.
Biology|April 3, 2021
The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular CarcinomaGian Paolo Caviglia, Maria Lorena Abate, Emanuela Rolle, et al.
JHEP Reports : Innovation in Hepatology|June 22, 2026
Impact of weight loss and reduction of ultra-processed foods on liver fat content in MASLD: a randomized controlled trialSimona Bo, Angelo Armandi, Gabriele Castelnuovo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2016
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver diseaseKonstantin Kazankov, Francisco Barrera, Holger Jon Møller, et al.
Pageof 33

Showing results (161-170 of 326) with videos related to

Sort By:
Pageof 33
Liver International : Official Journal of the International Association for the Study of the Liver|October 14, 2017
Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation studyRamy Younes, Chiara Rosso, Salvatore Petta, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatideMark L Hartman, Rohit Loomba, Eric J Lawitz, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2015
Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort studyClaudia Coppo, Daria Bonfanti, Simona Bo, et al.
Cancers|October 1, 2020
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular CarcinomaGian Paolo Caviglia, Michela Ciruolo, Antonella Olivero, et al.
NPJ Science of Food|March 5, 2026
Gut microbiome modulation by cricket, pea, and whey protein using the SHIME in vitro simulatorIrene Franciosa, Gabriele Castelnuovo, Carolina Cantele, et al.
International Journal of Cardiology|March 2, 2023
Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysisFabrizio D'Ascenzo, Francesco Bruno, Mario Iannaccone, et al.
Journal of Clinical Medicine|July 29, 2020
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with <i>Bifidobacterium Longum</i> ES1 for 8 or 12 Weeks: A Preliminary ReportGian Paolo Caviglia, Alessandra Tucci, Rinaldo Pellicano, et al.
Biology|April 3, 2021
The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular CarcinomaGian Paolo Caviglia, Maria Lorena Abate, Emanuela Rolle, et al.
JHEP Reports : Innovation in Hepatology|June 22, 2026
Impact of weight loss and reduction of ultra-processed foods on liver fat content in MASLD: a randomized controlled trialSimona Bo, Angelo Armandi, Gabriele Castelnuovo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2016
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver diseaseKonstantin Kazankov, Francisco Barrera, Holger Jon Møller, et al.
Pageof 33